A study on the relationship between air pollution and pulmonary tuberculosis based on the general additive model in Wulumuqi, China
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Authors: Yang, Jiandong; Zhang, Mengxi; Chen, Yanggui; Ma, Li; Yadikaer, Rayibai; Lu, Yaoqin; Lou, Pengwei; Pu, Yujiao; Xiang, Ran; Rui, Baolin
Abstract
Objective: This study aimed to explore the impact of atmospheric pollutants on the incidence of tuberculosis (TB), and provide new ideas for the prevention and control of TB in the future. Methods: It explored the relationship between air pollutants and meteorological factors, as well as between air pollutants and heating through Spearman correlation analysis and rank sum test. Additionally, it analyzed the relationship between air pollutants and TB incidence using the general additive model. Statistical analysis results at the p < 0.05 level were considered significant. Results: Three months after exposure to air pollutants (PM2.5, SO2, NO2, and CO) TB incidence increased. However, TB incidence increased 9 months after exposure to PM10. The single pollutant model showed when concentrations of PM2.5, PM10, SO2, NO2, CO, and O-3 increased by 1 mg/m(3) (or 1 mg/m(3)), the number of TB cases increased by 0.09%, 0.08%, 0.58%, 0.42%, 6.9%, and 0.57%, respectively. The optimal multi-pollutant model was a two-factor model (PM10 + NO2). Conclusion: Air pollutants including PM2.5, PM10, SO2, NO2, CO, and O-3 increased the risk of TB. Few studies have been conducted in this area of research, especially regarding the mechanism. The results of this study should contribute to the understanding of TB incidence and prompt additional research. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Exploring MDR-TB Inhibitory Potential of 4-Aminoquinazolines asMycobacterium tuberculosis N-Acetylglucosamine-1-Phosphate Uridyltransferase (GlmU(MTB)) Inhibitors
CHEMISTRY & BIODIVERSITY
Authors: Patel, Harun M.; Palkar, Mahesh; Karpoormath, Rajshekhar
Abstract
Drug resistance tuberculosis is one of the challenging tasks that dictates the desperate need for the development of new antitubercular agents which operatevianovel modes of action. Here, we are reporting on 4-aminoquinazolines asM. tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU(MTB)) inhibitors to overcome the problem of the MDR-TB. Amongst the synthesized compounds, two of them were observed to be the effective compounds of the series (IC50=6.4 mu M (H37Rv), MIC=25 mu M (MDR-TB) and IC50=2.9 mu M (H37Rv), MIC=6.25 mu M (MDR-TB), respectively).